Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands		12 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022
Net revenue:
Revenue		$ 446,551	$ 447,605	$ 429,909
Cost of revenue:
Total cost of revenue	[1]	303,630	293,645	269,954
Gross profit		142,921	153,960	159,955
Operating expenses:
Research and development	[2]	49,732	57,129	57,752
Selling and marketing		42,619	46,178	49,664
General and administrative		50,066	48,271	44,391
Total operating expenses		142,417	151,578	151,807
Income from operations		504	2,382	8,148
Income on equity method investment		1,838	2,572	241
Interest expense		(11,624)	(10,632)	(8,129)
Other expense, net		(2,538)	(1,110)	(2,262)
Total loss before provision for income taxes		(11,820)	(6,788)	(2,002)
Provision for income taxes		3,725	2,492	3,345
Net loss		$ (15,545)	$ (9,280)	$ (5,347)
Net loss per share, Basic		$ (0.16)	$ (0.1)	$ (0.06)
Net loss per share, Diluted		$ (0.16)	$ (0.1)	$ (0.06)
Weighted average common shares used in computing net loss per share:
Basic		98,272	94,884	92,095
Diluted		98,272	94,884	92,095
Net Income (Loss)		$ (15,545)	$ (9,280)	$ (5,347)
Foreign currency translation adjustment		(2,445)	(791)	(3,998)
Change in defined benefit pension obligation		(2,199)	(1,193)	4,311
Comprehensive loss		(20,189)	(11,264)	(5,034)
Products
Net revenue:
Revenue	[3]	234,164	233,192	214,715
Cost of revenue:
Total cost of revenue		161,061	153,627	127,287
Services
Net revenue:
Revenue	[4]	212,387	214,413	215,194
Cost of revenue:
Total cost of revenue		$ 142,569	$ 140,018	$ 142,667

[1] Includes cost of revenue from sales to the joint venture, an equity method investment, of $59,853 during the year ended June 30, 2024, $37,772 during the year ended June 30, 2023, and $35,237 during the year ended June 30, 2022, respectively. See Note 11.

[2] Includes charge backs to the joint venture, an equity method investment, related to research and development of $942 during the year ended June 30, 2024, $1,463 during the year ended June 30, 2023, and $2,336 during the year ended June 30, 2022, respectively.

[3] Includes sales of products to the joint venture, an equity method investment, of $77,497 during the year ended June 30, 2024, $55,658 during the year ended June 30, 2023, and $45,545 during the year ended June 30, 2022, respectively. See Note 11.

[4] Includes sales of services to the joint venture, an equity method investment, of $15,039 during the year ended June 30, 2024, $10,919 during the year ended June 30, 2023, and $10,332 during the year ended June 30, 2022, respectively. See Note 11.